The portfolio maintains a sizable cost advantage over competitors, priced within the least expensive fee quintile among peers.
Impax International Sust Econ Instl PXNIX
- NAV / 1-Day Return 11.27 / +0.45 %
- Total Assets 1.3 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.450%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 250,000
- Status Open
- TTM Yield 2.36%
- Turnover 56%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis PXNIX
Will PXNIX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 23.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Novo Nordisk AS Class B | 3.02 | 39.4 Mil | Healthcare |
AstraZeneca PLC | 2.77 | 36.2 Mil | Healthcare |
Novartis AG Registered Shares | 2.75 | 35.9 Mil | Healthcare |
ASML Holding NV | 2.41 | 31.5 Mil | Technology |
iShares Core MSCI EAFE ETF | 2.34 | 30.5 Mil | — |
HSBC Holdings PLC | 2.19 | 28.6 Mil | Financial Services |
Schneider Electric SE | 2.19 | 28.6 Mil | Industrials |
KDDI Corp | 2.00 | 26.2 Mil | Communication Services |
CSL Ltd | 1.96 | 25.6 Mil | Healthcare |
BNP Paribas Act. Cat.A | 1.89 | 24.6 Mil | Financial Services |